Impaired bone formation and increased osteoclastogenesis in mice lacking chemokine (C-C motif) ligand 5 (Ccl5)

Journal of Bone and Mineral Research

Volumn 28, Issue 10, 2013, Pages 2070-2080

  Wintges, Kristofer ^a   Beil, F Timo ^a   Albers, Joachim ^a   Jeschke, Anke ^a   Schweizer, Michaela ^a   Claass, Benjamin ^a   Tiegs, Gisa ^a   Amling, Michael ^a   Schinke, Thorsten ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

CCL5; chemokines; osteal macrophages; osteoimmunology

Indexed keywords

CD11B ANTIGEN; INTERLEUKIN 18; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE REMODELING; CELL DIFFERENTIATION; CELL TYPE; CORTICAL BONE; EX VIVO STUDY; GENE TARGETING; HEMATOPOIETIC CELL; MACROPHAGE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOPENIA; PHENOTYPE; SURFACE PROPERTY; TRABECULAR BONE;

CCL5; CHEMOKINES; OSTEAL MACROPHAGES; OSTEOIMMUNOLOGY;

ANIMALS; BONE MARROW CELLS; BONE REMODELING; CELL DIFFERENTIATION; CELL SEPARATION; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CCL5; CULTURE MEDIA, CONDITIONED; HEMATOPOIESIS; INTERLEUKIN-18; MACROPHAGES; MICE; MICE, INBRED C57BL; OSTEOCLASTS; OSTEOGENESIS; SPINE; STEM CELLS; TIBIA;

EID: 84884510607     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1937     Document Type: Article

References (29)

1. Lorenzo J, Horowitz M, Choi Y., Osteoimmunology: interactions of the bone and immune system. Endocr Rev. 2008; 29: 403-40.
2. Takayanagi H., Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol. 2007; 7: 292-304.
3. Sabatini M, Boyce B, Aufdemorte T, Bonewald L, Mundy GR., Infusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal mice. Proc Natl Acad Sci U S A. 1988; 85: 5235-9.
4. Jimi E, Nakamura I, Duong LT, Ikebe T, Takahashi N, Rodan GA, Suda T., Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp Cell Res. 1999; 247: 84-93.
5. Yamada N, Niwa S, Tsujimura T, Iwasaki T, Sugihara A, Futani H, Hayashi S, Okamura H, Akedo H, Terada N., Interleukin-18 and interleukin-12 synergistically inhibit osteoclastic bone-resorbing activity. Bone. 2002; 30: 901-8.
6. Schulze J, Bickert T, Beil FT, Zaiss MM, Albers J, Wintges K, Streichert T, Klaetschke K, Keller J, Hissnauer TN, Spiro AS, Gessner A, Schett G, Amling M, McKenzie AN, Horst AK, Schinke T., Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells. J Bone Miner Res. 2011; 26: 704-17.
7. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T, Kishimoto T, Suda T., IL-6 is produced by osteoblasts and induces bone resorption. J Immunol. 1990; 145: 3297-303.
8. De Benedetti F, Rucci N, Del Fattore A, Peruzzi B, Paro R, Longo M, Vivarelli M, Muratori F, Berni S, Ballanti P, Ferrari S, Teti A., Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system. Arthritis Rheum. 2006; 54: 3551-63.
9. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR., Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature. 1986; 319: 516-8.
10. Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, Taniguchi T., T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature. 2000; 408: 600-5.
11. Binder NB, Niederreiter B, Hoffmann O, Stange R, Pap T, Stulnig TM, Mack M, Erben RG, Smolen JS, Redlich K., Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis. Nat Med. 2009; 15: 417-24.
12. Yano S, Mentaverri R, Kanuparthi D, Bandyopadhyay S, Rivera A, Brown EM, Chattopadhyay N., Functional expression of beta-chemokine receptors in osteoblasts: role of regulated upon activation, normal T cell expressed and secreted (RANTES) in osteoblasts and regulation of its secretion by osteoblasts and osteoclasts. Endocrinology. 2005; 146: 2324-35.
13. Albers J, Schulze J, Beil FT, Gebauer M, Baranowsky A, Keller J, Marshall RP, Wintges K, Friedrich FW, Priemel M, Schilling AF, Rueger JM, Cornils K, Fehse B, Streichert T, Sauter G, Jakob F, Insogna KL, Pober B, Knobeloch KP, Francke U, Amling M, Schinke T., Control of bone formation by the serpentine receptor Frizzled-9. J Cell Biol. 2011; 192: 1057-72.
14. Rauner M, Stein N, Winzer M, Goettsch C, Zwerina J, Schett G, Distler JH, Albers J, Schulze J, Schinke T, Bornhäuser M, Platzbecker U, Hofbauer LC., WNT5A is induced by inflammatory mediators in bone marrow stromal cells and regulates cytokine and chemokine production. J Bone Miner Res. 2012; 27: 575-85.
15. Williams BO, Insogna KL., Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone. J Bone Miner Res. 2009; 24: 171-8.
16. Schinke T, Schilling AF, Baranowsky A, Seitz S, Marshall RP, Linn T, Blaeker M, Huebner AK, Schulz A, Simon R, Gebauer M, Priemel M, Kornak U, Perkovic S, Barvencik F, Beil FT, Del Fattore A, Frattini A, Streichert T, Pueschel K, Villa A, Debatin KM, Rueger JM, Teti A, Zustin J, Sauter G, Amling M., Impaired gastric acidification negatively affects calcium homeostasis and bone mass. Nat Med. 2009; 15: 674-81.
17. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR., Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987; 2: 595-610.
18. Chang MK, Raggatt LJ, Alexander KA, Kuliwaba JS, Fazzalari NL, Schroder K, Maylin ER, Ripoll VM, Hume DA, Pettit AR., Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo. J Immunol. 2008; 181: 1232-44.
19. Keller J, Catala-Lehnen P, Wintges K, Schulze J, Bickert T, Ito W, Horst AK, Amling M, Schinke T., Transgenic over-expression of interleukin-33 in osteoblasts results in decreased osteoclastogenesis. Biochem Biophys Res Commun. 2012; 417: 217-22.
20. Kawase Y, Hoshino T, Yokota K, Kuzuhara A, Nakamura M, Maeda Y, Nishiwaki E, Zenmyo M, Hiraoka K, Aizawa H, Yoshino K., Bone malformations in interleukin-18 transgenic mice. J Bone Miner Res. 2003; 18: 975-83.
21. Kimble RB, Vannice JL, Bloedow DC, Thompson RC, Hopfer W, Kung VT, Brownfield C, Pacifici R., Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. J Clin Invest. 1994; 93: 1959-67.
22. Cornish J, Gillespie MT, Callon KE, Horwood NJ, Moseley JM, Reid IR., Interleukin-18 is a novel mitogen of osteogenic and chondrogenic cells. Endocrinology. 2003; 144: 1194-201.
23. Tyner JW, Uchida O, Kajiwara N, Kim EY, Patel AC, O'Sullivan MP, Walter MJ, Schwendener RA, Cook DN, Danoff TM, Holtzman MJ., CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection. Nat Med. 2005; 11: 1180-7.
24. Charo IF, Ransohoff RM., The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med. 2006; 354: 610-21.
25. Levy JA., The unexpected pleiotropic activities of RANTES. J Immunol. 2009; 182: 3945-6.
26. Appay V, Rowland-Jones SL., RANTES: a versatile and controversial chemokine. Trends Immunol. 2001; 22: 83-7.
27. Yu X, Huang Y, Collin-Osdoby P, Osdoby P., CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts. J Bone Miner Res. 2004; 19: 2065-77.
28. Makino Y, Cook DN, Smithies O, Hwang OY, Neilson EG, Turka LA, Sato H, Wells AD, Danoff TM., Impaired T cell function in RANTES-deficient mice. Clin Immunol. 2002; 102: 302-9.
29. Pettit AR, Chang MK, Hume DA, Raggatt LJ., Osteal macrophages: a new twist on coupling during bone dynamics. Bone. 2008; 43: 976-82.